Skip to main content
Medicine BPC-157

A loud, gleefully over-the-top digest of the BPC-157 research record — every animal study, every honest data gap, and exactly where compounded medicinal access really stands, set on a retro-kitsch noticeboard.

PAGE 08: HOW TO REACH THE EDITORS

Send a source question or correction

You can report a broken link, wrong number, or missed study. The editors can’t answer personal health or product questions.

What you can ask the editors to check

A BPC-157 number may look wrong. A BPC-157 study link may fail. You may know of a paper the site missed.

Use the form for those notes. Tell us which page you read. We'll check the original source and fix a real error.

The editors can't give medical advice. They can't decide whether BPC-157 fits your health. They also can't discuss a personal amount.

BPC-157 isn't sold here. The editors won't name a seller, pharmacy, or clinic. They also won't name a service for video or phone visits with a doctor. This desk only checks published sources.

What the editors can do after your note

Editors treat your note as a source question. A request for personal health advice won't get an answer. The same goes for a request to obtain the drug.

Your doctor or another licensed health worker can discuss your health. This site can't discuss your case. It can only check published sources.

For pharmacy rules, start with the dated FDA record. On April 22, 2026, FDA no longer showed BPC-157 in Category 2, its list for raw ingredients with safety concerns. The page said the pharmacy review request was withdrawn.

FDA didn't say what that change lets a pharmacy mix. BPC-157 pharmacy rules and current status explains the open question in the FDA pages.

For study details, open BPC-157 research references. You'll find every source cited here. Then you can read each paper yourself.